The median expression levels of sHLA-G in GC patients were 8.50 ng/ml (0.53–127.0 ng/ml), while in benign pathology patients was 6.92 ng/ml (0.53–76.3 ng/ml). The gene discussed is HLA-G; the disease is gastric cancer.